ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal.

February 17, 2006

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004